{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:17Z","timestamp":1791920117016,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019540","name":"Science Fund for Distinguished Young Scholars of Zhejiang Province","doi-asserted-by":"publisher","award":["LR21H300003"],"award-info":[{"award-number":["LR21H300003"]}],"id":[{"id":"10.13039\/501100019540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973172"],"award-info":[{"award-number":["81973172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173660"],"award-info":[{"award-number":["82173660"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003579"],"award-info":[{"award-number":["82003579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173789"],"award-info":[{"award-number":["82173789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H300005"],"award-info":[{"award-number":["LQ21H300005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejmech.2024.116542","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T22:18:33Z","timestamp":1717280313000},"page":"116542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke"],"prefix":"10.1016","volume":"275","author":[{"given":"Yang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuqiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-4372","authenticated-orcid":false,"given":"Xiaowu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116542_bib1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s10637-018-0591-z","article-title":"A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors","volume":"36","author":"Aghajanian","year":"2018","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2024.116542_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2024.116542_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2019.11.024","article-title":"Embolic stroke of undetermined source: JACC review topic of the week","volume":"75","author":"Ntaios","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejmech.2024.116542_bib4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review","volume":"325","author":"Mendelson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2024.116542_bib5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2015.3058","article-title":"Acute stroke intervention: a systematic review","volume":"313","author":"Prabhakaran","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2024.116542_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2018.05.012","article-title":"Advances in stroke pharmacology","volume":"191","author":"Zhou","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.116542_bib7","first-page":"436","article-title":"Recurrent ischemic stroke: strategies for prevention","volume":"96","author":"Oza","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejmech.2024.116542_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jacc.2019.06.039","article-title":"Antithrombotic therapy to prevent recurrent strokes in ischemic cerebrovascular disease: JACC scientific expert panel","volume":"74","author":"Del Brutto","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejmech.2024.116542_bib9","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/STROKEAHA.120.028992","article-title":"Risk and secondary prevention of stroke recurrence: a population-base cohort study","volume":"51","author":"Flach","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2024.116542_bib10","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/jch.13653","article-title":"Assessing the applicability of 2017 ACC\/AHA hypertension guidelines for secondary stroke prevention in the BOSS study","volume":"21","author":"Xie","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ejmech.2024.116542_bib11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Investigators. Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116542_bib12","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2024.116542_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MJT.0b013e31814b17bf","article-title":"Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole","volume":"16","author":"Weyrich","year":"2009","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116542_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/11539160-0000000000-00000","article-title":"Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke","volume":"24","author":"Greer","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2024.116542_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(20)30433-6","article-title":"The role of diet in secondary stroke prevention","volume":"20","author":"English","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2024.116542_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","article-title":"Secondary stroke prevention","volume":"13","author":"Hankey","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2024.116542_bib17","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/CM9.0000000000000289","article-title":"Application and prospects of butylphthalide for the treatment of neurologic diseases","volume":"132","author":"Chen","year":"2019","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.ejmech.2024.116542_bib18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.14336\/AD.2020.1226","article-title":"DL-3-n-butylphthalide increases collateriogenesis and functional recovery after focal ischemic stroke in mice","volume":"12","author":"Wei","year":"2021","journal-title":"Aging Dis"},{"key":"10.1016\/j.ejmech.2024.116542_bib19","article-title":"Dl-3-N-Butylphthalide promotes angiogenesis in an optimized model of transient ischemic attack in C57bl\/6 mice","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116542_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2021.04.006","article-title":"Dl-3-n-butylphthalide pretreatment attenuates renal ischemia\/reperfusion injury","volume":"557","author":"Dong","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116542_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1871527317666180612125843","article-title":"Dl-3-n-Butylphthalide (NBP): a promising therapeutic agent for ischemic stroke","volume":"17","author":"Wang","year":"2018","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.ejmech.2024.116542_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12883-022-02815-x","article-title":"Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet","volume":"22","author":"Lv","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejmech.2024.116542_bib23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/bioinformatics\/btz695","article-title":"NERDD: a web portal providing access to in silico tools for drug discovery","volume":"36","author":"Stork","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2024.116542_bib24","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1021\/jm4001693","article-title":"Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents","volume":"56","author":"Wang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116542_bib25","first-page":"25","article-title":"Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1\/RIP3-exosome axis","volume":"9","author":"Zeng","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.ejmech.2024.116542_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/03602532.2021.1970178","article-title":"Drug metabolic stability in early drug discovery to develop potential lead compounds","volume":"53","author":"Gajula","year":"2021","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2024.116542_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1043-6618(02)00233-5","article-title":"Bilobalide and neuroprotection","volume":"46","author":"Defeudis","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116542_bib28","first-page":"956","article-title":"Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease","volume":"43","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2024.116542_bib29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/j.gastro.2019.07.058","article-title":"Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression","volume":"157","author":"Kuo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2024.116542_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41419-022-04591-5","article-title":"Autolysosomes and caspase-3 control the biogenesis and release of immunogenic apoptotic exosomes","volume":"13","author":"Beillevaire","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116542_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41420-021-00698-4","article-title":"Cell death inhibitors protect against brain damage caused by cardiac ischemia\/reperfusion injury","volume":"7","author":"Liao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116542_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","article-title":"Ischemic stroke: experimental models and reality","volume":"133","author":"Sommer","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2024.116542_bib33","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/s41401-022-00913-7","article-title":"Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window","volume":"43","author":"Pan","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116542_bib34","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1523\/JNEUROSCI.0341-17.2017","article-title":"Opening a new time window for treatment of stroke by targeting HDAC2","volume":"37","author":"Lin","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116542_bib35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2024.116542_bib36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/0271678X18762636","article-title":"Longitudinal in vivo intrinsic optical imaging of cortical blood perfusion and tissue damage in focal photothrombosis stroke model","volume":"39","author":"Yang","year":"2019","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejmech.2024.116542_bib37","article-title":"Modeling stroke in mice: focal cortical lesions by photothrombosis","volume":"171","author":"Llovera","year":"2021","journal-title":"J. Vis. Exp."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:22:32Z","timestamp":1720444952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424004227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"alternative-id":["S0223523424004227"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116542","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116542"}}